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Autophagy and apoptosis function as important early cellular defense mechanisms in infections and other diseases.
The outcome of an infection is determined by a complex interplay between the pathogenic microorganism and these
intracellular pathways. To better understand the cytopathogenicity of Herpes simplex virus types 1 and 2 (HSV-1 and -
2), we studied the effect of these viruses on the autophagic and apoptotic processes in the SIRC corneal cell line.
Infection with the KOS strain of HSV-1 and a wild-type strain of HSV-2 enhanced autophagosome formation,
triggered cytoplasmic acidification, increased LC3B lipidation and elevated the ratio of apoptotic cells. The autophagy
inhibitor bafilomycin A1 triggered a significant increase in the apoptotic responses of HSV-1- and HSV-2-infected
cells. Thus, both HSV types affect autophagy and apoptosis in a coordinated fashion, and autophagy plays
cytoprotective role in HSV-infected cells via antagonizing apoptosis. Together these data implicate autophagy in
the pathogenic mechanism of herpetic keratitis.
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1. Introduction
Herpes simplex virus types 1 and 2 (HSV-1 and -2) belong-
ing to the Herpesviridae family of large, enveloped DNA
viruses are capable of causing a wide array of human
diseases, including herpes simplex labialis, genital herpes,
encephalitis and ocular diseases, such as blepharitis, con-
junctivitis, keratitis, iridocyclitis and acute retinal necrosis
(Roizman and Pellett 2001; Vemuganti et al. 2011; Babu
et al. 2013; Rowe et al. 2013; Silva et al. 2013). During the
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course of herpetic keratitis, the HSV-induced cytopatho-
genicity together with the chronic immune-inflammatory
reaction can trigger stromal scarring, thinning and neo-
vascularization, leading to permanent vision impairment.
Herpetic keratitis therefore remains a frequent infectious
cause of blindness in many countries (Biswas and Rouse
2005; Choudhary et al. 2008; Rowe et al. 2013).
Tissue damage elicited by HSV-1 and -2 displays
cell-type-specific features. These viruses cause a lytic
infection in the epithelial cells and elicit tissue destruc-
tion characterized by complex cell death pattern
(Roizman and Pellett 2001; Nguyen and Blaho 2007).
In consequence of acquisition, HSV-1 and HSV-2 estab-
lish lifelong latency, inhibit apoptosis and maintain cell
survival within the neurons (Roizman and Pellett 2001).
Systemic and local stressors can interrupt the latency
and induce viral reactivation, leading to recrudescent
infections. The cytopathogenic mechanism of diseases
caused by HSV-1 and HSV-2 involves indirect, immune
processes and direct, virus-mediated events (Biswas and
Rouse 2005; Holdeman 2005; Kaye and Choudhary
2006; Fatahzadeh and Schwartz 2007; Choudhary et al.
2008).
Multiplication of these viruses subverts the physiolog-
ical regulation of apoptotic cell demise (Nguyen and
Blaho 2007 and 2009). Apoptosis, termed type I pro-
grammed cell death, is a type of cell deletion character-
ized by stereotypic cytomorphological changes, such as
nuclear compaction, DNA fragmentation to nucleosome-
sized fragments and cell shrinkage resulting in cellular
breakdown into membrane-bound apoptotic bodies. The
molecular events implicated in the activation of apopto-
tic cascade can be mediated by intrinsic and extrinsic
cellular pathways (Nguyen and Blaho 2009). It has been
shown that early in infection with HSV-1 or HSV-2, the
appearance of viral immediate early (IE) mRNAs acti-
vates the cellular apoptotic machinery. However, at 3 to
6 hours post-infection (hpi), several anti-apoptotic HSV
proteins [Infected Cell Protein 4 (ICP4), ICP22, ICP17,
ICP34.5, US3, US5, US6, UL14 and ICP10 of HSV-2],
as well as the latency-associated transcript inhibit apo-
ptotic demise, and maintain cell survival until the repli-
cation cycle is completed (Megyeri 2007). The time
period while anti-apoptotic HSV proteins are synthesized
is termed ‘apoptosis prevention window’ (Goodkin et al.
2003). In this phase of infection, the intricate balance of
pro- and anti-apoptotic factors is strongly biased by the
indirect influence of powerful cellular defense pathways,
such as the DNA damage response pathway or the
interferon system (Shirata et al. 2005). Finally, HSV
multiplication leads to the inevitable death of host cells,
at least in part via apoptotic mechanisms. Apoptosis
fulfils dual functions in the pathogenic mechanism of
diseases caused by HSV-1 and HSV-2; it contributes to
tissue damage and exerts antiviral effect by inhibiting
viral spread at the expense of killing infected cells.
HSV-1 and HSV-2 are also capable of modulating
autophagy, termed type II programmed cell death
(Tallóczy et al. 2001; Tallóczy et al. 2006; McFarlane
et al. 2011; Lussignol et al. 2013). Autophagy is an
essential catabolic process that maintains cellular integ-
rity by degrading cytoplasmic constituents and organelles
(Deretic and Levine 2009). It is highly activated by
several pathological conditions, including nutrient starva-
tion, oxidative stress, inflammation and infections
(Deretic and Levine 2009). Macroautophagy (herein re-
ferred to as autophagy) is one of the three ways the
cells can deliver sequestered cytoplasmic content, dam-
aged proteins, organelles or pathogens to the lysosomal
compartment using a double-membraned autophagosomal
vacuole as a carrying vehicle (Deretic and Levine 2009).
Under conditions of mild stress, autophagy plays a
cytoprotective role by eliminating pathogenic microor-
ganisms and dysfunctional organelles. In contrast, under
conditions leading to massive cell damage, excessive
autophagy possesses destructive power culminating in
cell demise (Chen and Klionsky 2011). It has been
shown that at the early stage of infection HSV-1 pro-
vokes autophagy (McFarlane et al. 2011). However,
some viral proteins (ICP34.5 and US11) synthesized
during the subsequent phases of productive infection
function as powerful inhibitors of the autophagic process
(Tallóczy et al. 2001; Tallóczy et al. 2006; Orvedahl
et al. 2007; Lussignol et al. 2013). ICP34.5 of HSV-1
antagonizes autophagy by binding Beclin-1, and by
blocking the double-stranded RNA-dependent protein ki-
nase/eukaryotic translation initiation factor 2α (PKR/
eIF2α) pathway (Tallóczy et al. 2006; Orvedahl et al.
2007). The HSV-1 US11 protein exerts anti-autophagic
activity via its direct interaction with PKR (Lussignol
et al. 2013). These interesting studies have shed light on
the importance of autophagy in infections caused by
HSV-1, and have successfully uncovered the underlying
molecular mechanisms in some experimental systems. At
present, much less is known about the effects of wild-
type HSV-2 on autophagy.
Our group previously described the importance of ap-
optosis in the cytopathogenicity of HSV-1 and demon-
strated the role of the pro-apoptotic p53 family member
TAp63γ in the pathogenic mechanism of ocular surface
disease caused by HSV-1 (Orosz et al. 2010). To further
understand the corneal processes induced by HSV-1 and
HSV-2, in the present study we investigated the effects of
these viruses on autophagy in the Statens Seruminstitut
Rabbit Cornea (SIRC) cell line, which displays many
features of corneal keratocytes (Niederkorn et al. 1990).
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2. Materials and methods
2.1 Cell culture and HSV growth
The SIRC cell line, was grown in Dulbecco’s modified Eagle's
minimal essential medium (Sigma Chemical Co., St. Louis,
MO, USA) supplemented with 10% fetal calf serum (FCS) at
37°C in a 5% CO2 atmosphere. For experiments, SIRC cell
cultures were inoculated with the KOS strain of HSV-1 or a
wild-type strain of HSV-2 at different multiplicities of infec-
tion (MOIs). Virus plaque assays were performed on confluent
monolayers of Vero cells inoculated with one or other HSV
solution for 1 h at 37°C and overlaid with 0.5% agarose in
phenol red-free Eagle’s minimum essential medium supple-
mented with 7.5% FCS and 2 mM L-glutamine. Plaque titers
were determined at 3 days after HSV infection.
2.2 Indirect immunofluorescence assay
Cytospin cell preparations were fixed in methanol-acetone
(1:1) for 15 min at −20°C. The slides were incubated with
specific antibodies to HSV glycoprotein D [(gD) (Sigma)],
autophagy-related gene 5 (Atg5) or microtubule-associated
protein 1 light chain 3B (LC3B) for 1 h at 37°C. After washing
with phosphate-buffered saline (PBS), the samples were
reacted with fluorescein isothiocyanate (FITC)-conjugated
species-specific antibodies (1:160) (Sigma) and incubated for
1 h at 37°C. After washing with PBS, the cells were visualized
by epifluorescence microscopy (Leica Microsystems GmbH,
Wetzlar, Germany). The ratio of positive to negative cells was
determined after counting 1,000 cells in random fields.
2.3 Transmission electron microscopy (TEM)
Samples were fixed in 0.1 M sodium cacodylate-buffered
2.5% glutaraldehyde solution (pH 7.4) for 2 h and then rinsed
three times for 10 min each in 0.1 M sodium cacodylate buffer
and 7.5% saccharose. The samples were post-fixed in 1%
OsO4 solution for 1 h. After dehydration in an ethanol gradient
(70%, 96% and 100% ethanol for 20 min each), samples were
embedded in Durcupan ACM. Ultrathin sections were stained
with uranyl acetate and lead citrate. Sections were examined in
a Philips CM 10 microscope (Philips Electronic Instruments,
Mahwah, NJ, USA) at 80 kV.
2.4 Acridine orange staining
Autophagy was assessed by the acridine orange staining pro-
cedure of autophagic vacuoles. The cells, grown on glass
coverslips were incubated for 15 min at 37°C in serum-free
medium containing 2 μg/mL 3,6-bis(dimethylamine)acridine.
After cells had been washed, fluorescent micrographs were
obtained using an epifluorescence microscope (Leica
Microsystems GmbH). Acridine orange accumulated by acidic
compartments emits orange fluorescence, whereas this meta-
chromatic dye bound to compartments with slightly acidic or
neutral pH emits green fluorescence.
2.5 Quantification of apoptosis by annexin V/propidium
iodide (AN/PI) double labelling
For AN/PI double labelling, the cells were stained with FITC-
labelled annexin V (AN-FITC) and propidium iodide (PI)
(MBL, Woburn, MA, USA) according to the manufacturer’s
instructions. The fluorescence intensities of AN-FITC and PI
were determined with a BD Bioscience flow cytometer (BD
Biosciences, San Diego, CA, USA). The percentages of apo-
ptotic cells were calculated by sorting the cells that were
positive only for AN (early apoptotic stage) or for both AN
and PI (late apoptotic or secondary necrotic stages).
2.6 Quantification of apoptosis by enzyme-linked
immunosorbent assay (ELISA)
For apoptosis ELISA, the cells were processed in a cell death
detection ELISA kit (Roche Diagnostics GmbH, Penzberg,
Germany). The cells were incubated in lysis buffer for 30 min
and centrifuged at 8000 rpm for 10 min. The supernatants were
transferred into a streptavidin-coated microplate and incubated
with biotin-conjugated anti-histone and peroxidase-conjugated
anti-DNAmonoclonal antibodies for 2 h. After washing, ABTS
substrate solution was added to each well for 15 min. Absor-
bance was measured at 405 and 490 nm. The specific enrich-
ment of mono- and oligonucleosomes was calculated as
enrichment factor EFð Þ ¼ absorbance of HSVinfected cells=absorbance of corresponding noninfected control cells:
2.7 Western blot assays
Cells were homogenized in CytoBuster lysis buffer
(Novagen, EMD Biosciences, Darmstadt, Germany), and
the mixture was then centrifuged at 10,000g for 10 min to
remove cell debris. Protein concentrations of cell lysates
were determined by using the Bio-Rad protein assay (Bio-
Rad, Hercules, CA, USA). Supernatants were mixed with
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Laemmli's sample buffer and boiled for 3 min. Aliquots of
the supernatants, containing 50 μg of total protein to detect
LC3B were resolved by SDS-PAGE and electrotransferred
onto nitrocellulose filters (Bio-Rad). Preblocked blots were
reacted with polyclonal antibody against LC3B (Sigma) for 4 h
in PBS containing 0.05% Tween 20, 1% dried non-fat milk
(Difco Laboratories, Detroit, MI, USA) and 1% BSA (Sigma).
Blots were then incubated for 2 h with peroxidase-conjugated
anti-rabbit antibody (DakoCytomation, Carpinteria, CA,
USA). Filters were developed by using a chemiluminescence
detection system (Thermo Fisher Scientific Inc., Rockford, IL,
USA). The autoradiographs were scanned with a GS-800
densitometer (Bio-Rad), and the relative band intensities were
quantified by use of the ImageQuant software (Molecular
Dynamics, Sunnyvale, CA, USA).
2.8 Statistical analysis
All values are expressed as mean ± standard deviation (SD).
The one-way ANOVA test with the Bonferroni post-test was
used for pairwise multiple comparisons, and p-values < 0.05
were considered statistically significant (GraphPad Prism 5,
GraphPad Software Inc., La Jolla, CA, USA).
3. Results
3.1 Effects of HSV-1 and HSV-2 on autophagy in the SIRC
cell line
To investigate the susceptibility of SIRC cells to the KOS
strain of HSV-1 and a wild-type HSV-2 strain, virus multi-
plication was assessed by using indirect immunofluores-
cence assay, Western blot and plaque titration. The data
demonstrated that both HSV-1 and HSV-2 could establish
a productive infection in this cell line (data not shown; Orosz
et al. 2010).
To study the effects of HSV-1 and HSV-2 on the process
of autophagy, SIRC cells were infected either with HSV-1 or
HSV-2 at an MOI of 1 and analysed by TEM and immuno-
fluorescence assay at 24 hpi.
TEM examination of the mock-infected culture revealed
normal cell morphology (figure 1A). In contrast, there were
numerous intracytoplasmic vacuoles in HSV-1-infected cells
(figures 1B–D). These vacuolar structures contained amor-
phous materials, organelles or virion particles (figures 1B–
D). The vacuoles were dispersed in the cytoplasm evenly
(figures 1B–D). This finding corresponds to the TEM picture
of excessive autophagy. This test has also provided
experimental proof of ongoing viral replication in SIRC
cells, as numerous assembled capsids and primarily
enveloped virions were revealed in the nuclei of infected
cells. Some fully matured cytoplasmic capsids and vi-
rions released from the cell in exocytotic vesicles were
also detected (figures 1B–D).
Indirect immunofluorescence assay to investigate the ef-
fect of HSV-1 on the intracellular localization of Atg5 and
LC3B revealed diffuse, cytoplasmic staining patterns in the
mock-infected cultures (figures 1E and G, respectively). In
contrast, HSV-1 increased the intensity of staining and trig-
gered translocation of Atg5 and LC3B from the cytoplasm to
distinct puncta in 67% and 93% of cells, respectively
(figures 1F and H, respectively). Together, these data dem-
onstrate that HSV-1 triggers the formation of autophagic
vacuoles, and alters the intracellular localization of Atg5
and LC3B.
To investigate the autophagic flux, bafilomycin A1
(BFLA) was used as a pharmacological tool to inhibit lyso-
somal degradative activity and to prevent fusion of
autophagosomes with lysosomes. As BFLA decreased the
production of infectious virions severely when it was present
throughout the infection (data not shown), an experimental
strategy that allows adsorption and uncoating to proceed
undisturbed was applied (figure 2A) (Harley et al. 2001).
The cells were infected either with HSV-1 or HSV-2 at an
MOI of 20, and incubated for 3 h. The cultures were then
treated with BFLA for an additional 12 h period, and
analysed for viral yields, apoptosis and LC3B expression
(figure 2A). Western blot analysis to quantify intracellular
gD protein revealed two bands migrating near 52 and 56 kDa
in HSV-1- or HSV-2-infected cells (figure 2B). This result is
fully consistent with previous observations demonstrating
that gD migrates as a doublet; the ~52 and ~56 kDa poly-
peptides correspond to the nonglycosylated and fully glyco-
sylated forms of gD, respectively (Balachandran et al. 1982;
Isaacs et al. 2000; Gianni et al. 2009). BFLA inhibited the
accumulation of this envelope glycoprotein in HSV-1- or
HSV-2-infected cells by 12.3% and 42.5%, respectively
(figure 2B). Plaque assay to quantify viral multiplication
revealed that BFLA retarded replication of HSV-1 and
HSV-2 by 52.6% and 13.6%, respectively (figure 2C). Thus,
the strategy involving delayed addition of BFLA provided
conditions when productive infection has occurred, though
at diminished levels compared to infected cultures incubated
in the absence of this autophagy inhibitor. Western blot
analysis to measure the levels of the lipidated and non-
lipidated forms of LC3B demonstrated that the mock-
infected culture displayed endogenous expression both of
LC3B-II and LC3B-I; the LC3B-II / LC3B-I ratio was 0.17
at 15 h of culturing (figure 2D, lane 6). Cells infected with
HSV-1 and HSV-2 displayed elevated LC3B-II and de-
pressed LC3B-I levels; the LC3B-II / LC3B-I ratios were
0.82 and 0.56, respectively (figure 2D, lanes 2 and 4, re-
spectively). This result demonstrates that HSV-1 and HSV-2
promote LC3B lipidation. BFLA highly elevated the level of
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LC3B-II (figure 2D, lane 1), indicating that this drug effi-
ciently blocked autophagy under the experimental conditions
used, and the pathways promoting LC3B-II accumulation
are intact in the SIRC cell line. In the presence of BFLA,
HSV-1 and HSV-2 triggered slightly lower increase in the
level of LC3B-II than that observed in the corresponding
drug control (figure 2D, lanes 3, 5 and 1, respectively). Thus,
both HSV-1 and HSV-2 decrease the autophagic flux to
some extent.
Acridine orange staining to detect autophagic vacuoles
revealed green cytoplasmic and nuclear staining in the
mock-infected cells at 24 h of culturing (figure 3A). The
nuclei of mock-infected cells were mostly round in shape
(figure 3A). In contrast, cells infected with HSV-1 or HSV-2
at an MOI of 1 displayed green nuclear and strong red
cytoplasmic fluorescence at 24 hpi, demonstrating that both
HSV types promote cytoplasmic acidification (figure 3A). In
HSV-1-infected cultures a few small syncytia, containing <5
nuclei, were observed, while HSV-2 infection resulted in the
formation of numerous large multinucleated giant cells,
which contained >50 nuclei (figure 3A). The nuclei of in-
fected cells had markedly irregular shape, contained disor-
ganized chromatin structures, and in some areas blurring,
folding or complete disruption of the nuclear membrane was
also observed (figure 3A).
3.2 Cell death pattern of HSV-1- and HSV-2-infected SIRC
cells
To investigate the cytopathogenicity of HSV-1 and HSV-2
in SIRC cultures, the cell death pattern of cultures infected at
an MOI of 1 was determined by AN/PI double labelling at 24
hpi.
Both HSV-1 and HSV-2 decreased the proportions of
viable cells by 32.9% and 57.8%, respectively (figure 3B).
The proportions of AN-single-positive (early apoptotic) and
double-positive (late apoptotic or secondary necrotic) cells in
Figure 1. HSV-1 infection increases the formation of autophagic vacuoles in SIRC cells. (A–D) Formation of autophagic vacuoles as
assessed by TEM: (A) Mock-infected cells; (B, C and D) cells infected with HSV-1. Red and green arrows indicate autophagic vacuoles and
viral particles, respectively. (E and F) Immunofluorescence assay for localization of Atg5: (E) Mock-infected cells; (F) cells infected with
HSV-1. (G and H) Immunofluorescence assay for localization of LC3B: (G) Mock-infected cells; (H) cells infected with HSV-1.
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HSV-1-infected cultures were increased by 15.4% and
13.3%, respectively (figure 3B). The proportions of
double-positive and PI-single positive (necrotic) cells were
increased by 36.5% and 23.8% in HSV-2-infected cultures,
respectively (figure 3B). Together, these data reveal that
both HSV-1 and HSV-2 trigger extensive cell demise.
3.3 Inhibition of autophagy increases apoptotic rates
of SIRC cells infected with HSV-1 and HSV-2
To investigate the potential connection between autophagy
and apoptosis, the effect of the autophagy inhibitor BFLA on
the extent of apoptosis was assessed. The cells were infected
either with HSV-1 or HSV-2 at an MOI of 20, and incubated
for 3 h. The cultures were then treated with BFLA for an
additional 12 h period, and analysed for apoptosis by
ELISA. The assay revealed significantly higher apoptotic
rates in HSV-1- and HSV-2-infected cells; the EFs for
HSV-1 and HSV-2 were 2.86 and 2.93, respectively
(figure 4). EFs for the HSV-1- and HSV-2-infected cells
incubated in the presence of BFLA were 6.36 and 4.32 vs
2.86 and 2.93 for the HSV-1- and HSV-2-infected cells
incubated in the absence of drug, respectively (figure 4).
Thus, BFLA triggered a significant increase in the apoptotic
responses of HSV-1- and HSV-2-infected cells as compared
with the corresponding infected controls incubated in the
absence of drug. Moreover, there was a significant difference
between the apoptosis inducing activities of HSV-1 and
HSV-2 in BFLA-treated cells (figure 4). Together, these
results demonstrate that inhibition of autophagy facilitates
apoptosis induced by HSV-1 and HSV-2.
4. Discussion
Apoptosis and autophagy are implicated in the maintenance
of ocular surface integrity both in physiological and patho-
logical conditions (Wilson 1999; Vemuganti et al. 2004;
Buron et al. 2006; Zoukhri et al. 2008). Compelling evi-
dence indicates that apoptosis is instrumental in glaucoma,
retinitis pigmentosa, cataract, retinoblastoma, retinal ische-
mia, diabetic retinopathy and several eye infections caused
Figure 2. HSV-1 and HSV-2 trigger LC3B lipidation, without in-
creasing the autophagic flux. (A) Graphical scheme of the experiments
designed to assess autophagic flux. (B) Detection of HSV gD and actin
by Western blot assay. Relative densities of HSV gD and actin were
measured by densitometric analysis of western blots. HSV gD was
normalized to actin, percentage changes of gD levels in HSV-infected
cells incubated with BFLA were compared to infected controls incu-
bated in the absence of BFLA, and the results are presented in graph
form below the image. (C) Detection of viral yield by plaque assay. (D)
Detection of LC3B and actin by Western blot assay. Relative densities
of LC3B-I, LC3B-II and actin were measured by densitometric analysis
of western blots. LC3B-I and LC3B-II were normalized to actin, and the
LC3B-II to LC3B-I ratio is shown below each lane.
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by viruses, bacteria, fungi and some protozoans (Kaneda
et al. 1999; Vemuganti et al. 2004; Cottet and Schorderet
2009; Zhang et al. 2010; Poznic M 2009; Barber et al. 2011;
Pinazo-Durán et al. 2013). In contrast, we are just beginning
to understand the role of autophagy in ocular diseases. As
herpetic keratitis continues to be a frequent and serious
medical problem, in this study we have investigated the role
of apoptosis and autophagy in the pathogenic mechanism of
direct corneal damage triggered by HSV-1 and HSV-2 in the
SIRC corneal cell line.
Remarkable studies focusing on the function of corneal
keratocytes in the maintenance of visual integrity have clear-
ly demonstrated that keratocytes, located in the corneal stro-
ma as a highly interconnected cellular network, undergo
apoptotic cell demise immediately after infections
(Vemuganti et al. 2004; West-Mays et al. 2006). The apo-
ptotic response of keratocytes operates as an important anti-
viral mechanism by inhibiting the spread of viruses to deeper
structures of the eye, and minimizes the inflammation that
accompanies corneal injury (Wilson et al. 1997; Vemuganti
e t a l . 2004 ; Mor i sh ige e t a l . 2006 ; Ambrós io
et al. 2009). In full accord with these findings our data have
corroborated that both HSV-1 and HSV-2 trigger apoptosis
in corneal cells.
Further interesting studies have demonstrated that the
effect of HSV-1 on autophagy is cell-type-specific. While
HSV-1 activates the STING (stimulator of interferon genes)-
dependent autophagy pathway in murine macrophages and
dendritic cells, neuroblastoma cells respond to HSV-1 infec-
tion with an abortive autophagy, and the anti-autophagic
effects of ICP34.5 and Us11 proteins dominate in fibroblasts
and primary murine neurons (Tallóczy et al. 2001; Tallóczy
et al. 2006; Orvedahl et al. 2007; Santana et al. 2012;
Lussignol et al. 2013). However, the impact of HSV infec-
tion on the autophagic process has not yet been elucidated in
corneal cells. Our analyses have revealed that HSV-1 facil-
itates the accumulation of autophagosomes, as well as the
recruitment of LC3B and Atg5 to autophagic vacuoles in the
Figure 3. HSV-1 and HSV-2 trigger cytoplasmic acidification and excessive cell death in SIRC cells. (A) Intracellular pH as assessed by
acridine orange staining. (B) Cell death pattern as assessed by AN/PI double labelling. The fluorescence intensities of AN-FITC and PI
were determined by flow cytometry. The two graphs show superimposed dot plots of fluorescence intensities either of HSV-1 or HSV-2 and
mock-infected cells.
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SIRC cell line. Our further experiments have also shown that
both HSV-1 and HSV-2 trigger LC3B lipidation, and in-
crease cytoplasmic acidification, without enhancing the au-
tophagic flux. Together, these results demonstrate that
autophagy is induced by both HSV-1 and HSV-2 in spite
of their effective anti-autophagic armamentarium, which
possibly impedes the process considerably via inhibiting
the fusion of autophagosomes with lysosomes.
Recent findings demonstrated that the apoptotic, autoph-
agic and necrotic pathways are interconnected and subject to
coordinated regulation (Jain et al. 2013). Autophagy can
operate as antagonist, facilitator or cooperator of apoptosis
depending on the nature of stressor and cellular context (Jain
et al. 2013). It has also been shown that HSV-1 elicits an
mTOR-independent pathway of autophagy, which in turn
prolongs survival of U251 glioma cells by counteracting
the coinciding apoptotic response (Tovilovic et al. 2013).
Thus, next we have asked whether autophagy has the poten-
tial to modulate apoptotic demise during the course of HSV-
1 and HSV-2 infection. Our results have revealed that apo-
ptotic cell demise induced by both HSV-1 and HSV-2 is
markedly enhanced by inhibition of autophagy indicating
that autophagy acts as antagonist of apoptosis in HSV-
infected SIRC cells. Induction of autophagy by HSV-1 and
HSV-2 may represent a viral strategy to provide sufficient
time for replication via inhibiting untimely apoptotic demise.
These data corroborate previous findings obtained with
HSV-1-infected U251 glioma cultures (Tovilovic et al.
2013), and extend the spectrum of cells in which HSV-
mediated induction of autophagy alleviates apoptosis. Under
circumstances when apoptosis is blocked, viral replication
can proceed in an undisturbed fashion, and the inevitable
demise of HSV-infected cells may preferably occur by way
of necrosis. This type of cell death may trigger a strong pro-
inflammatory response and thereby it may contribute to the
development of characteristic clinical symptoms seen in
keratitis patients. Together, these results may bear on kera-
titis, since dysregulation of keratocyte apoptosis may ac-
count for the structural and functional damage of cornea
occurring during the course of HSV infection. Moreover,
our further observation demonstrating a more remarkable
anti-apoptotic effect of autophagy in cultures infected with
HSV-1 than in HSV-2-infected cells suggests that the mech-
anism of corneal cytopathogenicity evoked by the two HSV
types might involve some different molecular mechanisms.
A better understanding of intrinsic autophagy evolving
during the course of herpes simplex keratitis and other in-
fections caused HSV-1 and HSV-2 may provide useful
knowledge for the development of novel therapeutic modal-
ities acting through autophagy modulation. A recent inter-
esting study revealed that rapamycin used topically in a
mouse model of HSK suppressed inflammation and neovas-
cularization (Zapata et al. 2012). In view of our present
findings obtained by using an in vitro SIRC corneal cell
model system, it is reasonable to infer that the beneficial
therapeutic efficiency of autophagy inducers in herpetic ker-
atitis may partly be due to their ability to reduce tissue
damage via counteracting apoptotic demise of infected cells.
Overall, this study demonstrates that HSV-1 and HSV-2
affect autophagy and apoptosis in a coordinated fashion, and
autophagy antagonizes apoptosis in HSV-infected cells. To-
gether these data implicate autophagy in the pathogenic
mechanisms of herpetic keratitis.
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1+BFLA.
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